| # | Drug | Count |
|---|---|---|
| 0 | MISOPROSTOL | 9 |
| 1 | FLUOXETINE | 2 |
| 2 | FLUOXETINE HYDROCHLORIDE | 2 |
| 3 | CELECOXIB | 1 |
| 4 | CLONAZEPAM | 1 |
| 5 | COPPER | 1 |
| 6 | DULAGLUTIDE | 1 |
| 7 | EMPAGLIFLOZIN | 1 |
| 8 | ETONOGESTREL AND ETHINYL ESTRADIOL | 1 |
| 9 | FLUOXETINE HCL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MISOPROSTOL | 9 | 0.0009 |
| 1 | FLUOXETINE HCL | 1 | 0.0002 |
| 2 | OXCARBAZEPINE | 1 | 0.0001 |
| 3 | ETONOGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0000 |
| 4 | COPPER | 1 | 0.0000 |
| 5 | HYDROXYZINE | 1 | 0.0000 |
| 6 | FLUOXETINE HYDROCHLORIDE | 2 | 0.0000 |
| 7 | EMPAGLIFLOZIN | 1 | 0.0000 |
| 8 | OMALIZUMAB | 1 | 0.0000 |
| 9 | DULAGLUTIDE | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostaglandin E1 Analog [EPC] | 9 |
| 1 | Anti-IgE [EPC] | 1 |
| 2 | Anti-epileptic Agent [EPC] | 1 |
| 3 | Benzodiazepine [EPC] | 1 |
| 4 | Copper-containing Intrauterine Device [EPC] | 1 |
| 5 | Estrogen [EPC] | 1 |
| 6 | GLP-1 Receptor Agonist [EPC] | 1 |
| 7 | Interferon beta [EPC] | 1 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 |
| 9 | Progestin [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostaglandin E1 Analog [EPC] | 9 | 0.0005 |
| 1 | Copper-containing Intrauterine Device [EPC] | 1 | 0.0000 |
| 2 | Anti-IgE [EPC] | 1 | 0.0000 |
| 3 | Serotonin Reuptake Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Estrogen [EPC] | 1 | 0.0000 |
| 6 | Interferon beta [EPC] | 1 | 0.0000 |
| 7 | Anti-epileptic Agent [EPC] | 1 | 0.0000 |
| 8 | Progestin [EPC] | 1 | 0.0000 |
| 9 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |